Haemophilus parainfluenzae is often isolated from the sputa of patients with chronic obstructive lung disease. We have investigated the immune response to this organism in patients with chronic bronchitis (n ‫؍‬ 3) and bronchiectasis (n ‫؍‬ 10) and in healthy controls (n ‫؍‬ 9). Outer membrane proteins (OMPs) of H. parainfluenzae were purified for use in enzyme-linked immunosorbent and immunoblot assays. Whole-cell H. parainfluenzae preparations were used to adsorb antibodies from serum samples, which were subsequently immunoblot assayed to investigate the antibody response to surface-exposed epitopes. Levels of H. parainfluenzae-specific immunoglobulin G (IgG), but not IgA or IgM, were increased in the sera of patients with chronic obstructive lung disease compared to levels in control subjects. The species specificity of the antibody response was confirmed, although a degree of cross-reactivity with H. influenzae antigens was observed. IgA and IgG specific for OMPs of H. parainfluenzae were demonstrated to be present in the sputa and sera of five patients with chronic obstructive lung disease. Variation in the pattern and intensity of antigen recognition was observed among patients and among immunoglobulin classes. OMPs of approximately 36, 22, and 15 kDa were confirmed to possess epitopes exposed on the surface of intact H. parainfluenzae. We have demonstrated the presence of a species-specific systemic immune response to H. parainfluenzae in colonized patients. A specific antibody response was also observed in sputum, and the antigen specificity of these responses in patients with chronic obstructive lung disease was investigated for the first time. The presence of a specific immune response suggests that H. parainfluenzae may have a pathogenic role in patients with chronic obstructive lung disease.
Haemophilus parainfluenzae, a common commensal organism of the normal oropharynx, is becoming recognized as an opportunistic pathogen causing systemic diseases with a spectrum similar to that of the closely related nontypeable Haemophilus influenzae (NTHI), including endocarditis, meningitis, and bacteremia (1, 4) . This species of Haemophilus has also been isolated from the sputa of patients with chronic obstructive lung disease (20) , but whereas the role of NTHI as a respiratory pathogen has become established, the role of H. parainfluenzae in both acute and chronic lung infections remains to be elucidated.
The presence of a specific antibody response, over and above that observed in healthy individuals, is often used as a marker of current or previous infection by a variety of infectious agents. Studies of the immune response to NTHI in patients with chronic obstructive lung disease have been important in establishing a pathogenic role for the organism (5, 7, 10, 13) . In addition, research has focused on the antigenicity of outer membrane proteins (OMPs) of NTHI (6, 8, 12, (16) (17) (18) , since naturally produced or vaccine-stimulated antibodies specific for surface-exposed epitopes of these proteins are important in immune-mediated bacterial clearance mechanisms. In contrast, few studies on either the presence or specificity of the immune response to H. parainfluenzae, particularly in patients with chronic obstructive lung disease, have been performed. The outer membrane composition of H. parainfluenzae is similar to that of other gram-negative bacteria and includes a major heat-modifiable protein of approximately 37 kDa, peptidoglycan-associated proteins (15, 27) , and lipopolysaccharides (21) . H. parainfluenzae also appears to exhibit diversity in OMP profiles similar to that of NTHI (21) ; however, in contrast to the case of NTHI, little work has been published regarding the antigenic characteristics of the major OMPs of H. parainfluenzae. Work on H. influenzae has established that this species has OMPs which include a heat-modifiable protein, P5; a porin, P2 (26, 27) ; and a peptidoglycan-associated lipoprotein, P6 (2). Suzuki et al. (24) have shown that the outer membrane of H. parainfluenzae also contains proteins which display homology to P2, P5, and the P6 precursor of H. influenzae. These proteins have all been considered as vaccine candidates for protection against H. influenzae infection; however, their importance as targets for antibodies in patients with chronic lung disease who are infected with H. parainfluenzae has not yet been investigated.
In order to provide evidence for or against a role for H. parainfluenzae as a pathogen in chronic lung disease, we performed a pilot study of patients with chronic bronchitis or bronchiectasis, who are frequently infected with or colonized by this species. We investigated the systemic antibody response in 13 of these patients (3 with chronic bronchitis and 10 with bronchiectasis) using an enzyme-linked immunosorbent assay (ELISA) and compared their levels of specific antibody to those in healthy controls (n ϭ 9). The species specificity of the response has been confirmed through adsorption of serum samples with either H. parainfluenzae or H. influenzae. We also investigated the patterns of OMP recognition of immunoglobulin G (IgG) and IgA in sputa and sera from five patients with chronic obstructive lung disease and the specificity of the systemic antibody response for epitopes exposed on the intact surface of H. parainfluenzae.
was provided by SDS-PAGE as described below. OMP preparations subjected to SDS-PAGE and stained with Fast Stain (Zoion Biotech, Worcester, Mass.) routinely had protein profiles similar to those observed by others (15, 28) , i.e., three major proteins of approximately 15, 37, and 40 kDa and a number of minor proteins.
SDS-PAGE and immunoblot assay. Immunoblot assays were used (i) to investigate the recognition of H. parainfluenzae OMPs by IgG and IgA in sputa and sera from patients with chronic obstructive lung disease who were regularly colonized with H. parainfluenzae and (ii) to measure the presence of H. parainfluenzae-specific antibodies in the products of adsorption and elution assays (as described below).
OMPs (25 g ) were subjected to SDS-PAGE on laneless modified Laemmli gels (containing 12.5% acrylamide) and either fixed (50% methanol, 10% glacial acetic acid) for total protein staining (Fast Stain; Zoion Biotech) or transferred to a Hybond nitrocellulose membrane (Amersham, Little Chalfont, United Kingdom) for immunoblot assay. The portion of the nitrocellulose containing the low-molecular-weight markers was separated and stained for total protein with colloidal gold (Aurodye forte; Amersham) or Fast Stain. The remainder of the nitrocellulose was immersed for 1 h at room temperature in Tris-buffered saline (0.05 M Tris-HCl, 0.15 M NaCl [pH 7.4]) with 0.1% Tween 20 (TTBS) containing 3% skim milk. The nitrocellulose was washed three times in TTBS and incubated in the presence of diluted serum, sputum sol phase, or buffer only for 1 h at room temperature and washed as before. The wash solution was replaced with peroxidase-conjugated sheep antibody specific for human IgG, IgA, and IgM in combination (diluted to 1/2,000 in TTBS; The Binding Site, Birmingham, United Kingdom) or for IgG or IgA alone (diluted to 1/2,000; Dako). After 1 h, the nitrocellulose was washed again and color was developed for 10 min with VIP development solution (Vector Laboratories Ltd., Petersborough, United Kingdom), after which the nitrocellulose was rinsed in distilled water and allowed to dry.
Adsorption and elution assay. Adsorption of serum antibodies by whole H. parainfluenzae was modified from the protocols of Loeb (11) and Sethi et al. (22) . Three different isolates of H. parainfluenzae were isolated from the sputa of bronchiectatic patients regularly colonized with this species and were used to adsorb antibodies from sera collected from the same patients. Sputa and sera were collected on the same day. The isolated strains of H. parainfluenzae were grown to stationary phase in 3 ml of BHI broth supplemented with NAD and hemin (10 g/ml) and inoculated into 75 ml of supplemented BHI broth. These were incubated for 6 to 8 h at 37°C until the absorbance of the bacterial suspensions reached 0.3 at 600 nm. The bacteria were harvested by centrifugation (12,000 ϫ g for 10 min at 4°C), washed at 4°C by resuspension in 10 ml of PCM buffer (0.01 M Na 2 PO 4 , 0.15 M NaCl, 0.15 mM CaCl 2 , 0.5 mM MgCl 2 [pH 7.2]), and centrifuged as before. The pellets were resuspended in 1 ml of PCM buffer in a microcentrifuge tube and pelleted at high speed in a microcentrifuge for 5 min at 4°C. The supernatant was discarded and the bacterial pellet was gently resuspended in 1 ml of heat-inactivated serum (1/200). The suspensions were incubated on ice for 30 min with gentle mixing every 5 min, followed by centrifugation at maximum speed in a microcentrifuge for 15 min at 4°C. The supernatant was transferred to a fresh microcentrifuge tube and centrifuged as before, and the final supernatant was transferred to another microcentrifuge tube and stored at Ϫ20°C as adsorbed serum. A control organism, Escherichia coli, was subjected to the protocol simultaneously.
Antibodies were eluted from intact bacteria as follows. Briefly, strains of H. parainfluenzae or E. coli were subjected to the adsorption protocol described above, with the exception that serum was diluted to 1/10. The bacterial pellet was retained at the end of the procedure and the adsorbed serum was discarded. The pellet was washed three times with 1 ml of PCM buffer by resuspension and centrifugation at maximum speed in a microcentrifuge for 2 min at 4°C. The pellet was then resuspended in 1 ml of elution buffer (0.2 M NaCl, 0.2 M glycine [pH 2.8]) and incubated for 30 min at room temperature on an orbital shaker at 300 rpm. Native serum, adsorbed serum, and eluted antibodies were tested in immunoblot assays for the presence of antibodies which could recognize antigens in an OMP preparation of the isolate of H. parainfluenzae which was used to perform the adsorption and elution assay.
RESULTS
ELISA for antibodies to H. parainfluenzae. Levels of IgG, IgA, and IgM antibody against whole-cell H. parainfluenzae antigens in the sera of 13 patients with chronic obstructive lung disease (10 with bronchiectasis and 3 with chronic bronchitis) and 9 healthy control subjects are shown in Fig. 1 . Antibody recognizing H. parainfluenzae was found to be present in all patients and control subjects studied, with the exception of a single control subject in whom only specific IgM was undetectable. Levels of H. parainfluenzae-reactive IgG were significantly higher in patients than in controls (mean absorbance in patients, 0.51; standard deviation [SD], 0.23; mean absorbance in controls, 0.26; SD, 0.15; P Ͻ 0.01). Mean levels of IgA and IgM recognizing H. parainfluenzae were lower than those of IgG in patients and controls, and no significant differences were observed between the two groups with regard to IgA (mean absorbance in patients, 0.22; SD, 0.15; mean absorbance in controls, 0.15; SD, 0.11) or IgM (mean absorbance in patients, 0.07; SD, 0.05; mean absorbance in controls, 0.08; SD, 0.07). There was a significant inverse correlation between bacterial load in sputum and levels of reactive IgG in serum (Spearman's rank correlation coefficient [r], Ϫ0.57; 2P Ͻ 0.05) (Fig. 2) . There was no significant correlation between bacterial load and IgA or IgM.
The species specificity of the antibody reacting with a wholecell preparation of H. parainfluenzae was tested by comparing the results of the ELISA after serum samples from all of the patients had been adsorbed with either sonicated whole-cell preparations of H. parainfluenzae or similar preparations of H. influenzae. Results are shown in Fig. 3 , along with the level of reactive antibody measured in unadsorbed serum. A reduction in H. parainfluenzae-reactive IgG was observed after adsorption of serum with H. influenzae (for unadsorbed sera, the mean absorbance was 0.79 and the SD was 0.33; for sera adsorbed with H. influenzae, the mean absorbance was 0.29 and the SD was 0.11 [P Ͻ 0.001]). However, a far greater reduction was observed when serum samples were adsorbed with H. parainfluenzae (mean absorbance, 0.06; SD, 0.03), resulting in levels which were significantly lower than those both in unadsorbed serum (P Ͻ 0.001) and in serum adsorbed with H. influenzae (P Ͻ 0.001).
Immunoblot assay of serum and sputum sol phase. Sera (1/100) and sputum sol phase (1/10) from five patients (two with chronic bronchitis and three with bronchiectasis) were immunoblot assayed for the presence of IgG and IgA specific for OMPs prepared from a single strain (CF3115) of H. parainfluenzae (Fig. 4a) . Staining by IgG-specific antibodies was more intense than that by IgA-specific antibodies. Similar patterns of recognition were observed when sputum and serum from the same patient were compared, although patterns did vary among individuals. Samples from two patients displayed low levels of staining of OMPs by sputum IgG (Fig. 4a, lanes B  and D) . Generally, staining was most intense in IgG-specific assays of serum, whereas for IgA, sputum provided more intense staining than serum. Overall, the specificities of IgG and IgA varied in that an antigen of approximately 22 kDa and several more between 45 and 66 kDa were recognized by IgG only. Two antigens consistently recognized by IgG and IgA had approximate molecular masses of 15 and 37 kDa.
Pooled serum and induced sputum sol phase obtained from healthy controls were also immunoblot assayed for the presence of IgG, IgA, and IgM antibodies recognizing OMP antigens of strain CF3115 (Fig. 4b) . Two antigens of approximately 15 and 37 kDa were recognized faintly by antibodies in serum (Fig. 4b, lane C) . Staining by sputum antibodies was negligible.
No specific staining of the buffer-only control (Fig. 4b , lane D) was observed in either of the above assays.
Adsorption and elution assay. Three adsorption assays were performed; the results of one are shown in Fig. 5 . In two of the assays, three H. parainfluenzae OMPs (approximate molecular masses of 37, 22, and 15 kDa) were recognized by IgG, IgA, and IgM antibodies in heat-treated homologous serum, and two OMPs (22 and 15 kDa) were recognized by IgG, IgA, and IgM in heat-treated serum from the remaining patient. In all assays, adsorption of sera with the control organism, E. coli (Fig. 5, lane B) , had no effect on the intensity of antibody recognition of H. parainfluenzae OMPs. Adsorption with intact H. parainfluenzae (Fig. 5, lane C) , however, reduced the recognition of OMPs to negligible levels. After adsorption, antibodies specific for H. parainfluenzae OMPs could be eluted from the surface of H. parainfluenzae (Fig. 5, lane F) but not from the surface of similarly treated E. coli (Fig. 5, lane E) .
DISCUSSION
H. parainfluenzae is isolated from the sputa of patients with chronic lung disease in relatively large numbers and at a frequency similar to that of accepted respiratory pathogens such as NTHI (9) . Little work, however, has been performed investigating the contribution of this species to the pathogenesis of chronic lung disease, and since, like other members of the genus including NTHI, H. parainfluenzae is frequently isolated from the oropharynx, it has been regarded as a contaminating commensal organism when isolated from sputa. In this pilot study we have therefore begun to investigate the antibody response to H. parainfluenzae as part of our studies of the role of this species in chronic lung infection.
Results from the ELISA described here demonstrated that patients who were regularly colonized with H. parainfluenzae had higher levels of serum IgG specific for this organism than did healthy control subjects (Fig. 1) . Patients with chronic lung disease, however, are likely to have been colonized with NTHI, and H. parainfluenzae is known to possess antigens which crossreact with rabbit antibodies to H. influenzae (23) . The specificity of the systemic immune response observed in our patients was therefore confirmed through adsorption of serum samples with whole-cell preparations of either NTHI or H. parainfluenzae prior to measurement of H. parainfluenzae-reactive IgG by ELISA. Adsorption with NTHI reduced the amount of IgG specific for H. parainfluenzae in serum samples (Fig. 3) , though this was to be expected since a sonicated whole-cell preparation was used. This preparation is certain to contain antigens shared with a variety of bacterial species, including H. parainfluenzae (23) , and will therefore adsorb cross-reactive antibody in serum samples tested. Adsorption of native serum with H. parainfluenzae, however, resulted in a reduction of reactive antibody to very low levels (P Ͻ 0.001; 13 times lower than that observed after adsorption with H. influenzae). This result, together with the data from the original ELISA, strongly indicates that there is an elevated systemic IgG response to H. parainfluenzae in patients from whom this organism is frequently isolated. Interestingly, there was an inverse correlation between bacterial load in the sputa of these patients and levels of H. parainfluenzae-reactive IgG in their sera. It is possible that in patients with lower levels of reactive IgG, the larger numbers of colonizing bacteria in their airways are a consequence of lower levels of opsonizing antibody transudating from serum to airway secretions. It is not possible, however, to draw any firm conclusions from the small number of patients studied here.
Immunoblot assays were performed in an effort to identify which OMPs of H. parainfluenzae were recognized by specific antibodies in sera and sputa from patients with chronic obstructive lung disease. IgG and IgA antibodies specific for OMPs were demonstrated to be present in both the sera and sputa of the patients studied. Up to 14 different OMPs of the single strain of H. parainfluenzae studied, ranging from 15 to 70 kDa, were recognized by serum IgG. Recognition by sputum IgG followed a similar pattern of staining but was generally of lower intensity. Fewer antigens were recognized by IgA in serum or sputum, but two antigens, of 37 and 15 kDa, were most consistently recognized by IgA and IgG. The exact identity of these OMPs is unknown, but it is possible that the 37-kDa OMP is the same as that described by Suzuki et al. (24) and possesses some homology to the porin protein, P2, of NTHI. The consistent antibody recognition of the 15-kDa OMP is similar to that previously observed for P6 (a 16-kDa, surface-exposed, antigenically conserved lipoprotein of NTHI) in patients with bronchiectasis (14) . Bogdan and Apicella (3) have shown that of the Haemophilus species, H. parainfluenzae is the only one that does not contain the protein P6. Suzuki and colleagues (24) , however, have identified an OMP which exhibits homology to the OMP P6 precursor of H. influenzae, and it is therefore possible that H. parainfluenzae possesses a closely related protein.
Since antibody-mediated clearance of infecting organisms can succeed only in the presence of antibodies recognizing epitopes exposed by live bacteria, the potential functional significance of the antibody response to H. parainfluenzae in these patients was investigated by using intact bacteria isolated from their sputa to adsorb antibodies from their sera. Antibodies reacting with surface-exposed epitopes were then eluted from the surface of the bacteria, and the results were visualized by immunoblot assay. The 36-and 15-kDa antigens described above, together with a 22-kDa antigen (recognized by serum IgG in three of the five patients' samples) initially studied by immunoassay, were demonstrated to possess surface-exposed epitopes, which suggests that they may be important in immune recognition and antibody-dependent clearance mechanisms.
These initial studies, therefore, have demonstrated the presence of a specific immune response in the sera and sputa of a group of patients with chronic obstructive lung disease who are colonized by or frequently infected with H. parainfluenzae. We have shown that a variety of OMPs are recognized by antibodies in these patients but that apparently only three of these possess epitopes exposed on the surface of the intact bacteria. Further studies are necessary to confirm the identity of these antigens and to measure the functional capabilities of antibodies recognizing H. parainfluenzae in these patients.
